Astria Therapeutics to Participate in Upcoming Investor Conferences
-
Oppenheimer’s 32nd Annual Healthcare Conference: On
March 17, 2022 at12:40pm ET ,Jill C. Milne , Ph.D., Chief Executive Officer, will present a corporate overview and provide information on lead program STAR-0215. -
Guggenheim Healthcare Talks, 2022 Genomic Medicines and Rare Disease:
Astria Therapeutics will be participating in the conference, which will take place onMarch 31 andApril 1, 2022 .
A live webcast of the Oppenheimer presentation can be accessed at the following link: https://wsw.com/webcast/oppenheimer20/atxs/2810304. An archived replay of the presentation will be available in the investors section of www.astriatx.com for 30 days following the event.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20220309005065/en/
Astria Contacts:
Investor relations:
investors@astriatx.com
Media:
media@astriatx.com
Source: